Messenger RNA editing of the human serotonin 5-HT2C receptor

被引:78
作者
Fitzgerald, LW [1 ]
Iyer, G [1 ]
Conklin, DS [1 ]
Krause, CM [1 ]
Marshall, A [1 ]
Patterson, JP [1 ]
Tran, DP [1 ]
Jonak, GJ [1 ]
Hartig, PR [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Expt Stn, CNS Dis Res, Res Labs, Wilmington, DE 19880 USA
关键词
RNA editing; mCPP; serotonin receptor; transcriptional modification; LSD; efficacy; intrinsic activity;
D O I
10.1016/S0893-133X(99)00004-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
RNA encoding the rat serotonin 5-HT2C receptor undergoes editing whereby am to four adenosines nm converted to inosines. This conversion can change up to three codons out of a stretch of five in the second intracellular loop of the receptor. RNA editing of the rat 5-HT2C receptor that changes all three codons was shown previously to alter intracellular signaling by 5-HT without changing ifs receptor-binding affinity. We analyzed 5-HT2C receptor editing in human brain and hypothalamic RNA samples and confirmed that all four adenosine editing sites observed in rat were also present in human samples. Additionally, we identified a novel editing site in the middle edited codon that extends the repertoire of 5-HT2C receptors by six additional protein isoforms. We observed that editing reduces both the binding affinity and functional potency of agonists for recombinant human 5-HT2C receptor isoforms. This effect on binding affinity was proportional to the agonist's intrinsic activity, with full agonists most affected, and antagonists showing no effect. These data suggest that RNA editing may alter coupling energetics within the ternary complex, thereby altering agonist binding affinities, G protein coupling, and functional responses. RNA editing may thus provide a novel mechanism for regulating 5-HT synaptic signaling and plasticity. (C) 1999 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:S82 / S90
页数:9
相关论文
共 23 条
  • [1] EDITING FOR AN AMPA RECEPTOR SUBUNIT RNA IN PREFRONTAL CORTEX AND STRIATUM IN ALZHEIMERS-DISEASE, HUNTINGTONS-DISEASE AND SCHIZOPHRENIA
    AKBARIAN, S
    SMITH, MA
    JONES, EG
    [J]. BRAIN RESEARCH, 1995, 699 (02) : 297 - 304
  • [2] Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus
    Berg, KA
    Maayani, S
    Goldfarb, J
    Scaramellini, C
    Leff, P
    Clarke, WP
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (01) : 94 - 104
  • [3] LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS
    BERRIDGE, MJ
    DOWNES, CP
    HANLEY, MR
    [J]. BIOCHEMICAL JOURNAL, 1982, 206 (03) : 587 - 595
  • [4] Regulation of serotonin-2C receptor G-protein coupling by RNA editing
    Burns, CM
    Chu, H
    Rueter, SM
    Hutchinson, LK
    Canton, H
    SandersBush, E
    Emeson, RB
    [J]. NATURE, 1997, 387 (6630) : 303 - 308
  • [5] Canton H, 1996, MOL PHARMACOL, V50, P799
  • [6] Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
    Egan, CT
    Herrick-Davis, K
    Miller, K
    Glennon, RA
    Teitler, M
    [J]. PSYCHOPHARMACOLOGY, 1998, 136 (04) : 409 - 414
  • [7] Fitzgerald LW, 1998, J PHARMACOL EXP THER, V287, P448
  • [8] GOMEZA T, 1996, J BIOL CHEM, V271, P2199
  • [9] Hartig PR, 1997, HANDB EXP PHARM, V129, P175
  • [10] APOLIPOPROTEIN-B MESSENGER-RNA EDITING - A NEW TIER FOR THE CONTROL OF GENE-EXPRESSION
    HODGES, P
    SCOTT, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (02) : 77 - 81